Evidence map›Paper›PMID 34302474›Full record

Trial reportJournal of the National Cancer Institute2022

Simplifying Survivorship Care Planning: A Randomized Controlled Trial Comparing 3 Care Plan Delivery Approaches.

Claire Snyder, Youngjee Choi, Amanda L Blackford, Jennifer DeSanto, Nancy Mayonado, Susan Rall, Sharon White, Janice Bowie, David E Cowall, Fabian Johnston and 8 more

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the National Cancer Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Feasibility of delivering survivorship care via lay health educators: A pilot randomized controlled trial among rural cancer survivors.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2023
    Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Claire SnyderJohns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-8952-4561
Youngjee ChoiJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Amanda L BlackfordJohns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
Jennifer DeSantoJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0001-6499-9536
Nancy MayonadoTidalHealth Richard A. Henson Research Institute, Salisbury, MD, USA.ORCID 0000-0003-0622-1181
Susan RallTidalHealth Richard A. Henson Research Institute, Salisbury, MD, USA.
Sharon WhiteJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Janice BowieJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
David E CowallTidalHealth Richard A. Henson Research Institute, Salisbury, MD, USA.ORCID 0000-0001-6758-3536
Fabian JohnstonJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Robert L JoynerTidalHealth Richard A. Henson Research Institute, Salisbury, MD, USA.ORCID 0000-0002-7228-2671
Joan MischtschukTidalHealth Richard A. Henson Research Institute, Salisbury, MD, USA.ORCID 0000-0003-4355-2174
Kimberly S PeairsJohns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-9475-2534
Elissa ThornerJohns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
Phuoc T TranJohns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-0147-0376
Antonio C WolffJohns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-3734-1063
Katherine C SmithJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0003-2140-1690
SSCP Stakeholder Advisory Board

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6M
NCI NIH HHS P30 CA006973
6 · The paper itself

Abstract

backgroundSurvivorship care plans seek to improve the transition to survivorship, but the required resources present implementation barriers. This randomized controlled trial aimed to identify the simplest, most effective approach for survivorship care planning.

methodsStage 1-3 breast, colorectal, and prostate cancer patients aged 21 years or older completing treatment were recruited from an urban-academic and rural-community cancer center. Participants were randomly assigned, stratified by recruitment site and cancer type 1:1:1 to a mailed plan, plan delivered during a 1-time transition visit, or plan delivered during a transition visit plus 6-month follow-up visit. Health service use data were collected from participants and medical records for 18 months. The primary outcome, receipt of all plan-recommended care, was compared across intervention arms using logistic regression adjusting for cancer type and recruitment site, with P less than .05 considered statistically significant.

resultsOf 378 participants randomly assigned, 159 (42.1%) were breast, 142 (37.6%) prostate, and 77 (20.4%) colorectal cancer survivors; 207 (54.8%) from the academic site and 171 (45.2%) from the community site; 316 were analyzable for the primary outcome. There was no difference across arms in the proportion of participants receiving all plan-recommended care: 45.2% mail, 50.5% 1-visit, 42.7% 2-visit (2-sided P = .60). Adherence by cancer type for mail, 1-visit, and 2-visit, respectively, was 52.2%, 53.3%, and 40.0% for breast cancer; 48.6%, 64.1%, and 57.1% for prostate cancer; and 23.8%, 19.0%, and 26.1% for colorectal cancer. There were no statistically significant interactions by recruitment site or cancer type.

conclusionsThis study did not find differences in receipt of recommended follow-up care by plan delivery approach. Feasibility and other factors may determine the best approach for survivorship care planning.

Indexed as

Cancer SurvivorsNeoplasmsPatient Care PlanningAdultAftercareFemaleHumansMaleSurvivorshipYoung Adult

Identifiers

PMID34302474
PMCPMC8755486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.